| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
22,390,000 |
| Market
Cap: |
2.56(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1145 - $0.4797 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vaccinex is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat diseases and conditions with unmet medical needs. Co.'s main platform technologies include: semaphorin 4D (SEMA4D) antibody platform, which is the application of its knowledge of SEMA4D biology to develop its main product candidate pepinemab for the treatment of various indications, including cancer and neuroinflammatory and neurodegenerative diseases; and ActivMAb antibody discovery platform, which is a proprietary human antibody discovery platform based on a method for expressing libraries of human monoclonal antibodies on the surface of mammalian pox viruses.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
282 |
282 |
3,510,282 |
3,510,282 |
| Total Buy Value |
$1,334 |
$1,334 |
$3,510,849 |
$3,510,849 |
| Total People Bought |
1 |
1 |
2 |
2 |
| Total Buy Transactions |
1 |
1 |
5 |
5 |
| Total Shares Sold |
0 |
4,483 |
4,483 |
4,483 |
| Total Sell Value |
$0 |
$3,161 |
$3,161 |
$3,161 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
2 |
2 |
2 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fcmi Parent Co. |
10% Owner |
– – • |
2019-03-15 |
4 |
AB |
$3.96 |
$3,960 |
I/I |
1,000 |
4,790,469 |
|
- |
|
| Vaccinex (rochester), L.l.c. |
10% Owner |
– – • |
2019-03-15 |
4 |
AB |
$3.96 |
$3,960 |
I/I |
1,000 |
4,790,469 |
|
- |
|
| Vaccinex (rochester), L.l.c. |
10% Owner |
– – • |
2019-03-15 |
4/A |
AB |
$3.96 |
$3,960 |
I/I |
1,000 |
4,790,469 |
|
- |
|
| Fcmi Parent Co. |
10% Owner |
– – • |
2019-03-14 |
4 |
AB |
$4.00 |
$4,000 |
I/I |
1,000 |
4,789,469 |
|
- |
|
| Vaccinex (rochester), L.l.c. |
10% Owner |
– – • |
2019-03-14 |
4 |
AB |
$4.00 |
$4,000 |
I/I |
1,000 |
4,789,469 |
|
- |
|
| Vaccinex (rochester), L.l.c. |
10% Owner |
– – • |
2019-03-14 |
4/A |
AB |
$4.00 |
$4,000 |
I/I |
1,000 |
4,789,469 |
|
- |
|
| Royer Scott E. |
Chief Financial Officer |
• – – |
2019-02-07 |
4 |
B |
$5.05 |
$8,711 |
D/D |
1,725 |
3,999 |
2.74 |
- |
|
| Royer Scott E. |
Chief Financial Officer |
• – – |
2019-02-06 |
4 |
B |
$4.57 |
$1,257 |
D/D |
275 |
2,274 |
2.66 |
- |
|
| Royer Scott E. |
Chief Financial Officer |
• – – |
2019-01-15 |
4 |
B |
$4.31 |
$7,275 |
D/D |
1,688 |
1,999 |
2.74 |
- |
|
| Royer Scott E. |
Chief Financial Officer |
• – – |
2018-12-27 |
4 |
B |
$4.15 |
$1,291 |
D/D |
311 |
311 |
2.66 |
- |
|
| Fcmi Parent Co. |
10% Owner |
– – • |
2018-08-13 |
4 |
B |
$12.00 |
$29,499,996 |
I/I |
2,458,333 |
583,333 |
1.5 |
- |
|
| Fcmi Parent Co. |
10% Owner |
– – • |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,506,808 |
2,913,469 |
|
- |
|
| Fcmi Parent Co. |
10% Owner |
– – • |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
439,555 |
439,555 |
|
- |
|
| Vaccinex (rochester), L.l.c. |
President and CEO |
– – • |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,006,594 |
815,698 |
|
- |
|
| Vaccinex (rochester), L.l.c. |
President and CEO |
– – • |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
93,547 |
177,748 |
|
- |
|
| Shumacher Michael |
10% Owner |
– – • |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,895,583 |
1,895,583 |
|
- |
|
| Frieberg Jacob B. |
Director |
– • – |
2018-08-09 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
13,574 |
|
- |
|
67 Records found
|
|
Page 3 of 3 |
|
|
